Total Funding
74
48
Total FundingPost-IPO Equity raised
Growth Score
-9 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
44614
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
- Peter Francis: Chief Scientific Officer & Therapeutic Area Head, OphthalmologyPast Role: 4D Molecular Therapeutics, Chief Medical Officer & Head of Translational R&D
- Julie Clark: Chief Medical OfficerPast Role: 4D Molecular Therapeutics, SVP of Clinical Research & Development
About the Company
4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Women Founded
